SCHEMBL8776940

SCHEMBL8776940

CCS(=O)(=O)c1ccc(-c2ccc(SC)nc2-c2ccc(SC)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.42
PTGS1 P23219 3/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
ALOX15 P16050 1/20 0.35
GAA P10253 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
PSIP1 O75475 2/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
KCNH2 Q12809 1/20 0.33
PLAU P00749 1/20 0.33
AURKA O14965 2/20 0.33
KDR P35968 2/20 0.33
NTRK1 P04629 1/20 0.33
AURKB Q96GD4 1/20 0.33
PLK4 O00444 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086695 0.86 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL19013847 0.76 PSIP1 (0.54) PTGS2ALDH1A1LMNAALOX15GAA
SCHEMBL8776742 0.69 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL8421555 0.65 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL3570249 0.64 PSIP1 (0.56) ALDH1A1LMNAALOX15GAAPOLB
SCHEMBL7778081 0.63 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL10455034 0.63 PSIP1 (0.74) ALDH1A1LMNAGAAPOLBPSIP1
SCHEMBL7780009 0.62 CA2 (0.44) PTGS2PTGS1LMNA
SCHEMBL6726429 0.60 PTGS2 (0.62) PTGS2PTGS1
SCHEMBL2035701 0.60 TSHR (0.50) PTGS2ALDH1A1LMNAALOX15POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP claimed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO claimed